BTIG announced today that it will host its 19th BTIG Commissions for Charity Day on Tuesday, May 20, 2025. The firm’s signature philanthropic event is celebrated across BTIG’s 20 global ...

BTIG analyst Ryan Zimmerman maintained a Buy rating on Stryker (SYK – Research Report) today and set a price target of $403.00. The company’s shares closed last Friday at $350.28. Discover ...

Investing.com -- BTIG upgraded Snowflake Inc (NYSE:SNOW) to "Buy" from "Neutral" and introduced a $220 price target on improving demand trends and potential AI-driven growth. The brokerage noted ...

On Wednesday, BTIG analyst Carl Reichardt Jr. maintained a Neutral rating on shares of NVR Inc . (NYSE:NVR), while slightly lowering earnings per share (EPS) estimates for the upcoming years.

BTIG analysts warn that "significant divergences still remain heading into 2H" in a recent note. The investment firm highlights the underperformance of small-cap stocks and lingering questions ...

NEW YORK, June 27, 2024--(BUSINESS WIRE)--BTIG announced today that Daniil Kalyuzhny has joined the firm as a Managing Director within its Healthcare Investment Banking group. Based in the firm ...

In a recent note, BTIG acknowledged that reports the Biden administration was getting ready to propose such an action marked a “watershed moment” for the cannabis industry. However ...

BTIG sees increased stability for the medtech sector in 2024 as it moves past concerns about the impact of GLP-1 weight-loss drugs, supply chain snarls, and higher interest rates. “With GLP-1 ...

On November 13, global investment banking firm BTIG filed a lawsuit in California state court against rival company StoneX Group, alleging trade secret and breach of contract claims related to a ...

“BTIG contends that StoneX was able to access BTIG’s proprietary software code and business strategies by hiring a series of six former BTIG employees.” On November 13, global investment ...

Nov 13 (Reuters) - U.S. brokerage firm BTIG on Monday sued rival StoneX Group Inc (SNEX.O), opens new tab in San Francisco, accusing it of stealing trade secrets and seeking at least $200 million ...

As of August 2, 2023, the average one-year price target for Vericel is 41.56. The forecasts range from a low of 37.37 to a high of $44.10. The average price target represents an increase of 30.30% ...